Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Glucotrack (GCTK) Shares Outstanding (Weighted Average) (2016 - 2020)

Glucotrack's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $15.4 billion for Q3 2020.

  • For the quarter ending Q3 2020, Shares Outstanding (Weighted Average) rose 9421.46% year-over-year to $15.4 billion, compared with a TTM value of $15.4 billion through Sep 2020, up 9421.46%, and an annual FY2019 reading of $154.9 million, up 1745.09% over the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2020 was $15.4 billion at Glucotrack, roughly flat from $15.4 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $15.4 billion in Q3 2020, with the low at $5.7 million in Q1 2016.
  • Average Shares Outstanding (Weighted Average) over 5 years is $1.7 billion, with a median of $7.6 million recorded in 2018.
  • Year-over-year, Shares Outstanding (Weighted Average) increased 5.54% in 2016 and then soared 10198.66% in 2020.
  • Tracing GCTK's Shares Outstanding (Weighted Average) over 5 years: stood at $5.8 million in 2016, then grew by 8.58% to $6.3 million in 2017, then surged by 33.59% to $8.4 million in 2018, then surged by 1745.09% to $154.9 million in 2019, then soared by 9856.79% to $15.4 billion in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Shares Outstanding (Weighted Average) are $15.4 billion (Q3 2020), $15.4 billion (Q2 2020), and $181.8 million (Q1 2020).